Atlas Trials

Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function

Clinical trial NCT01563562 · COMPLETED

Trial details

NCT number
NCT01563562
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic ImpairmentHealthy
Start date
2012-04-30
Primary completion
2012-11-30
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.